Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 1-2, 2010, Pages 116-134

  Mimeault, Murielle ^a,b   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Aging; Anti aging therapies; Cancer therapies; Molecular targeting; Senescence; Skin cancer stem progenitor cells; Skin resident adult stem progenitor cells

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; BIOLOGICAL THERAPY; CELL AGING; CYTOLOGY; DISEASE MODEL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; MELANOMA; PATHOLOGY; PHYSIOLOGY; REGENERATION; REVIEW; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR; STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL AGING; DISEASE MODELS, ANIMAL; HUMANS; MELANOMA; REGENERATION; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; SKIN PHYSIOLOGICAL PROCESSES; STEM CELLS; TISSUE THERAPY;

EID: 77951956356     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00885.x     Document Type: Review

References (255)

1. Mimeault M, Bonenfant D, Batra SK. New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers. Skin Pharmacol Physiol. 2004, 17:153-6.
2. Mimeault M, Batra SK. Recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells. 2006, 24:2319-45.
3. McCullough JL, Kelly KM. Prevention and treatment of skin aging. Ann NY Acad Sci. 2006, 1067:323-31.
4. Benitah SA. Epidermal stem cells in skin homeostasis and cutaneous carcinomas. Clin Transl Oncol. 2007, 9:760-6.
5. Zouboulis CC, Baron JM, Bohm M. Frontiers in sebaceous gland biology and pathology. Exp Dermatol. 2008, 17:542-51.
6. Muller EJ, Williamson L, Kolly C. Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation. J Invest Dermatol. 2008, 128:501-16.
7. Fuchs E. Skin stem cells: rising to the surface. J Cell Biol. 2008, 180:273-84.
8. Fuchs E, Horsley V. More than one way to skin. Genes Dev. 2008, 22:976-85.
9. Tumbar T, Guasch G, Greco V. Defining the epithelial stem cell niche in skin. Science. 2004, 303:359-63.
10. Webb A, Li A, Kaur P. Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation. 2004, 72:387-95.
11. Larderet G, Fortunel NO, Vaigot P. Human side population keratinocytes exhibit long-term proliferative potential and a specific gene expression profile and can form a pluristratified epidermis. Stem Cells. 2006, 24:965-74.
12. Blanpain C, Lowry WE, Geoghegan A. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004, 118:635-48.
13. Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol. 2006, 22:339-73.
14. Ito M, Liu Y, Yang Z. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med. 2005, 11:1351-4.
15. Levy V, Lindon C, Zheng Y. Epidermal stem cells arise from the hair follicle after wounding. FASEB J. 2007, 21:1358-66.
16. Li L, Xie T. Stem cell niche: Structure and function. Annu Rev Cell Dev Biol. 2005, 21:605-31.
17. Horsley V, O'Carroll D, Tooze R. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell. 2006, 126:597-609.
18. Nishimura EK, Jordan SA, Oshima H. Dominant role of the niche in melanocyte stem-cell fate determination. Nature. 2002, 416:854-60.
19. Sieber-Blum M, Grim M, Hu YF. Pluripotent neural crest stem cells in the adult hair follicle. Dev Dyn. 2004, 231:258-69.
20. Yu H, Fang D, Kumar SM. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol. 2006, 168:1879-88.
21. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science. 2005, 307:720-4.
22. Benitah SA, Frye M, Glogauer M. Stem cell depletion through epidermal deletion of Rac1. Science. 2005, 309:933-5.
23. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007, 8:703-13.
24. Youn SW, Kim DS, Cho HJ. Cellular senescence induced loss of stem cell proportion in the skin in vitro. J Dermatol Sci. 2004, 35:113-23.
25. Pillai S, Oresajo C, Hayward J. Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation - a review. Int J Cosmet Sci. 2005, 27:17-34.
26. Roh C, Lyle S. Cutaneous stem cells and wound healing. Pediatr Res. 2006, 59:100R-3R.
27. Kwon OS, Yoo HG, Han JH. Photoaging-associated changes in epidermal proliferative cell fractions in vivo. Arch Dermatol Res. 2008, 300:47-52.
28. Mimeault M, Batra SK. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications. Aging Res Rev. 2009, 8:94-112.
29. Chen W, Kang J, Xia J. p53-related apoptosis resistance and tumor suppression activity in UVB-induced premature senescent human skin fibroblasts. Int J Mol Med. 2008, 21:645-53.
30. Briganti S, Wlaschek M, Hinrichs C. Small molecular antioxidants effectively protect from PUVA-induced oxidative stress responses underlying fibroblast senescence and photoaging. Free Radic Biol Med. 2008, 45:636-44.
31. Moreau M, Neveu M, Stephan S. Enhancing cell longevity for cosmetic application: a complementary approach. J Drugs Dermatol. 2007, 6:S14-9.
32. Lavu S, Boss O, Elliott PJ. Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov. 2008, 7:841-53.
33. Ingram DK, Zhu M, Mamczarz J. Calorie restriction mimetics: an emerging research field. Aging Cell. 2006, 5:97-108.
34. Neugebauer RC, Sippl W, Jung M. Inhibitors of NAD+ dependent histone deacetylases (sirtuins). Curr Pharm Des. 2008, 14:562-73.
35. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006, 5:493-506.
36. Athar M, Back JH, Tang X. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007, 224:274-83.
37. Baxter RA. Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation. J Cosmet Dermatol. 2008, 7:2-7.
38. Shay JW, Wright WE. Use of telomerase to create bioengineered tissues. Ann NY Acad Sci. 2005, 1057:479-91.
39. Yoshikawa T, Mitsuno H, Nonaka I. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg. 2008, 121:860-77.
40. Kung EF, Wang F, Schechner JS. In vivo perfusion of human skin substitutes with microvessels formed by adult circulating endothelial progenitor cells. Dermatol Surg. 2008, 34:137-46.
41. Zhang CP, Fu XB. Therapeutic potential of stem cells in skin repair and regeneration. Chin J Traumatol. 2008, 11:209-21.
42. Park BS, Jang KA, Sung JH. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg. 2008, 34:1323-6.
43. Branski LK, Gauglitz GG, Herndon DN. A review of gene and stem cell therapy in cutaneous wound healing. Burns. 2008, 35:171-80.
44. Chen S, Takahara M, Kido M. Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma. Br J Dermatol. 2008, 159:952-5.
45. Lupi O. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma. Int J Dermatol. 2007, 46:1113-7.
46. Bachmann IM, Puntervoll HE, Otte AP. Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Mod Pathol. 2008, 21:583-90.
47. Athar M, Tang X, Lee JL. Hedgehog signalling in skin development and cancer. Exp Dermatol. 2006, 15:667-77.
48. Erb P, Ji J, Kump E. Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008, 624:283-95.
49. Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008, 624:162-78.
50. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol. 2005, 32:191-205.
51. Pons M, Quintanilla M. Molecular biology of malignant melanoma and other cutaneous tumors. Clin Transl Oncol. 2006, 8:466-74.
52. Pacifico A, Goldberg LH, Peris K. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. Br J Dermatol. 2008, 158:291-7.
53. Liu ZJ, Xiao M, Balint K. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 2006, 66:4182-90.
54. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer. 2003, 3:559-70.
55. Tchernev G, Orfanos CE. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings. J Cutan Pathol. 2007, 34:247-56.
56. Hutchin ME, Kariapper MS, Grachtchouk M. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev. 2005, 19:214-23.
57. Malanchi I, Peinado H, Kassen D. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature. 2008, 452:650-3.
58. Frank NY, Margaryan A, Huang Y. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 2005, 65:4320-33.
59. Fang D, Nguyen TK, Leishear K. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 2005, 65:9328-37.
60. Dou J, Pan M, Wen P. Isolation and identification of cancer stem-like cells from murine melanoma cell lines. Cell Mol Immunol. 2007, 4:467-2.
61. Monzani E, Facchetti F, Galmozzi E. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer. 2007, 43:935-46.
62. Keshet GI, Goldstein I, Itzhaki O. MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun. 2008, 368:930-6.
63. Schatton T, Murphy GF, Frank NY. Identification of cells initiating human melanomas. Nature. 2008, 451:345-9.
64. Grichnik JM, Burch JA, Schulteis RD. Melanoma, a tumor based on a mutant stem cell. J Invest Dermatol. 2006, 126:142-53.
65. Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells. 2008, 26:3008-17.
66. Ackermann J, Frutschi M, Kaloulis K. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 2005, 65:4005-11.
67. Lacina L, Dvorankova B, Smetana K. Marker profiling of normal keratinocytes identifies the stroma from squamous cell carcinoma of the oral cavity as a modulatory microenvironment in co-culture. Int J Radiat Biol. 2007, 83:837-48.
68. Marsh D, Dickinson S, Neill GW. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res. 2008, 68:3295-303.
69. Ruiter D, Bogenrieder T, Elder D. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol. 2002, 3:35-43.
70. Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 2002, 21:3919-26.
71. Kloepper JE, Tiede S, Brinckmann J. Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp Dermatol. 2008, 17:592-609.
72. Kamstrup M, Faurschou A, Gniadecki R. Epidermal stem cells - role in normal, wounded and pathological psoriatic and cancer skin. Curr Stem Cell Res Ther. 2008, 3:146-50.
73. Pellegrini G, Dellambra E, Golisano O. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA. 2001, 98:3156-61.
74. Jost M, Kari C, Rodeck U. The EGF receptor - an essential regulator of multiple epidermal functions. Eur J Dermatol. 2000, 10:505-10.
75. Jensen KB, Watt FM. Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a reg ulator of stem cell quiescence. Proc Natl Acad Sci USA. 2006, 103:11958-63.
76. Nguyen BC, Lefort K, Mandinova A. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 2006, 20:1028-42.
77. Devgan V, Nguyen BC, Oh H. p21WAF1/Cip1 suppresses keratinocyte differentiation independently of the cell cycle through transcriptional up-regulation of the IGF-I gene. J Biol Chem. 2006, 281:30463-70.
78. Kim DS, Cho HJ, Yang SK. IGFBP-2 Contributes to the proliferation of less proliferative cells in forming skin equivalents. Tissue Eng Part A. 2009, 15:1075-80.
79. Okuyama R, Ogawa E, Nagoshi H. p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene. 2007, 27:848-56.
80. Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature. 2005, 437:275-80.
81. Okuyama R, Lefort K, Dotto GP. A dynamic model of keratinocyte stem cell renewal and differentiation: role of the p21WAF1/Cip1 and Notch1 signaling pathways. J Investig Dermatol Symp Proc. 2004, 9:248-52.
82. Lefort K, Mandinova A, Ostano P. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev. 2007, 21:562-77.
83. Kolev V, Mandinova A, Guinea-Viniegra J. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol. 2008, 10:902-11.
84. Takeda K, Takeuchi O, Tsujimura T. Limb and skin abnormalities in mice lacking IKKalpha. Science. 1999, 284:313-6.
85. Li Q, Lu Q, Estepa G, Verma IM. Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc Natl Acad Sci USA. 2005, 102:15977-82.
86. Richardson RJ, Dixon J, Malhotra S. Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet. 2006, 38:1329-34.
87. Ingraham CR, Kinoshita A, Kondo S. Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet. 2006, 38:1335-40.
88. Zhu F, Xia X, Liu B. IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing. Mol Cell. 2007, 27:214-27.
89. Liu B, Xia X, Zhu F. IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell. 2008, 14:212-25.
90. Lyle S, Christofidou-Solomidou M, Liu Y. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci. 1998, 3179-88. 111 (Pt 21)
91. Roh C, Tao Q, Photopoulos C. In vitro differences between keratinocyte stem cells and transit-amplifying cells of the human hair follicle. J Invest Dermatol. 2005, 125:1099-105.
92. Levy V, Lindon C, Harfe BD. Distinct stem cell populations regenerate the follicle and interfollicular epidermis. Dev Cell. 2005, 9:855-61.
93. Ito M, Yang Z, Andl T. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature. 2007, 447:316-20.
94. Trempus CS, Morris RJ, Bortner CD. Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol. 2003, 120:501-11.
95. Ohyama M, Terunuma A, Tock CL. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2006, 116:249-60.
96. Lee S-H, Chung M-K, Sohn Y-J. Human hair follicle cells with the cell surface marker CD34 can regenerate new mouse hair follicles and located in the outer root sheath of immunodeficient nude mice. Int J of Stem cells. 2009, 1:70-81.
97. Flores I, Canela A, Vera E. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 2008, 22:654-67.
98. Flores I, Cayuela ML, Blasco MA. Effects of telomerase and telomere length on epidermal stem cell behavior. Science. 2005, 309:1253-6.
99. Sarin KY, Cheung P, Gilison D. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature. 2005, 436:1048-52.
100. Choi J, Southworth LK, Sarin KY. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 2008, 4. e10
101. Rajaraman S, Choi J, Cheung P. Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo. Proc Natl Acad Sci USA. 2007, 104:17747-52.
102. Ghali L, Wong ST, Green J. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin. J Invest Dermatol. 1999, 113:595-9.
103. Huelsken J, Vogel R, Erdmann B. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell. 2001, 105:533-45.
104. Yamamoto N, Tanigaki K, Han H. Notch/RBP-J signaling regulates epidermis/hair fate determination of hair follicular stem cells. Curr Biol. 2003, 13:333-8.
105. Vidal VP, Chaboissier MC, Lutzkendorf S. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr Biol. 2005, 15:1340-51.
106. Kasper M, Schnidar H, Neill GW. Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol. 2006, 26:6283-98.
107. Gat U, DasGupta R, Degenstein L. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell. 1998, 95:605-14.
108. Zhang Y, Andl T, Yang SH. Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. Development. 2008, 135:2161-72.
109. Estrach S, Ambler CA, Lo CC. Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development. 2006, 133:4427-38.
110. Demehri S, Kopan R. Notch signaling in bulge stem cells is not required for selection of hair follicle fate. Development. 2009, 136:891-6.
111. Osawa M, Egawa G, Mak SS. Molecular characterization of melanocyte stem cells in their niche. Development. 2005, 132:5589-99.
112. Chin L, Garraway LA, Fisher DE. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 2006, 20:2149-82.
113. Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008, 128:2365-80.
114. Na GY, Paek SH, Park BC. Isolation and characterization of outer root sheath melanocytes of human hair follicles. Br J Dermatol. 2006, 155:902-9.
115. Nishikawa S, Osawa M. Generating quiescent stem cells. Pigment Cell Res. 2007, 20:263-70.
116. Mak SS, Moriyama M, Nishioka E. Indispensable role of Bcl2 in the development of the melanocyte stem cell. Dev Biol. 2006, 291:144-53.
117. Aubin-Houzelstein G, Djian-Zaouche J, Bernex F. Melanoblasts' proper location and timed differentiation depend on Notch/RBP-J signaling in postnatal hair follicles. J Invest Dermatol. 2008, 128:2686-95.
118. Kumano K, Masuda S, Sata M. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. Pigment Cell Melanoma Res. 2008, 21:70-8.
119. Schouwey K, Delmas V, Larue L. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev Dyn. 2007, 236:282-9.
120. Moriyama M, Osawa M, Mak SS. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol. 2006, 173:333-9.
121. Belmadani A, Jung H, Ren D. The chemokine SDF-1/CXCL12 regulates the migration of melanocyte progenitors in mouse hair follicles. Differentiation. 2009, 77:395-411.
122. Yang G, Li Y, Nishimura EK. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell. 2008, 32:554-63.
123. Jeon S, Kim NH, Kim JY. Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration. Pigment Cell Melanoma Res. 2009, 22:77-85.
124. Sieber-Blum M, Grim M. The adult hair follicle: cradle for pluripotent neural crest stem cells. Birth Defects Res C Embryo Today. 2004, 72:162-72.
125. Hu YF, Zhang ZJ, Sieber-Blum M. An epidermal neural crest stem cell (EPI-NCSC) molecular signature. Stem Cells. 2006, 24:2692-702.
126. Yoshida H, Kunisada T, Grimm T. Review: melanocyte migration and survival controlled by SCF/c-kit expression. J Investig Dermatol Symp Proc. 2001, 6:1-5.
127. Schouwey K, Beermann F. The Notch pathway: hair graying and pigment cell homeostasis. Histol Histopathol. 2008, 23:609-19.
128. Rendl M, Lewis L, Fuchs E. Molecular Dissection of Mesenchymal-Epithelial Interactions in the Hair Follicle. PLoS Biol. 2005, 3:1910-24.
129. Kawase Y, Yanagi Y, Takato T. Characterization of multipotent adult stem cells from the skin: transforming growth factor-beta (TGF-beta) facilitates cell growth. Exp Cell Res. 2004, 295:194-203.
130. Fernandes KJ, McKenzie IA Mill P. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol. 2004, 6:1082-93.
131. Amoh Y, Li L, Campillo R. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci USA. 2005, 102:17734-8.
132. Wong CE, Paratore C, Dours-Zimmermann MT. Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol. 2006, 175:1005-15.
133. Toma JG, Akhavan M, Fernandes KJ. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol. 2001, 3:778-84.
134. Belicchi M, Pisati F, Lopa R. Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res. 2004, 77:475-86.
135. Mimeault M, Hauke R, Batra SK. Stem cells - A revolution in therapeutics-Recent advances on the stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther. 2007, 82:252-64.
136. Lorenz K, Sicker M, Schmelzer E. Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol. 2008, 17:925-32.
137. Zengin E, Chalajour F, Gehling UM. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 2006, 133:1543-51.
138. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol. 2004, 287:C572-9.
139. Wu Y, Wang J, Scott PG. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007, 15:S18-26.
140. Fisher GJ, Varani J, Voorhees JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol. 2008, 144:666-72.
141. Hayward NK. Genetics of melanoma predisposition. Oncogene. 2003, 22:3053-62.
142. Varani J, Dame MK, Rittie L. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006, 168:1861-8.
143. Kang J, Chen W, Xia J. Extracellular matrix secreted by senescent fibroblasts induced by UVB promotes cell proliferation in HaCaT cells through PI3K/AKT and ERK signaling pathways. Int J Mol Med. 2008, 21:777-84.
144. Borlon C, Vankoningsloo S, Godard P. Identification of p53-dependent genes potentially involved in UVB-mediated premature senescence of human skin fibroblasts using siRNA technology. Mech Ageing Dev. 2008, 129:109-19.
145. Wong KK, Maser RS, Bachoo RM. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature. 2003, 421:643-8.
146. Calado RT, Young NS. Telomere maintenance and human bone marrow failure. Blood. 2008, 111:4446-55.
147. Marrone A, Sokhal P, Walne A. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica. 2007, 92:1013-20.
148. Yamamoto K, Nihrane A, Aglipay J. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis. Mol Med. 2008, 14:167-74.
149. Meshorer E, Gruenbaum Y. Gone with the Wnt/Notch: stem cells in laminopathies, progeria, and aging. J Cell Biol. 2008, 181:9-13.
150. Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol. 2008, 10:452-9.
151. Bergoglio V, Magnaldo T. Nucleotide excision repair and related human diseases. Genome Dyn. 2006, 1:35-52.
152. Stout GJ, Blasco MA. Genetic dissection of the mechanisms underlying telomere-associated diseases: impact of the TRF2 telomeric protein on mouse epidermal stem cells. Dis Model Mech. 2009, 2:139-56.
153. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev. 2008, 88:557-79.
154. Mason PJ, Wilson DB, Bessler M. Dyskeratosis congenita - a disease of dysfunctional telomere maintenance. Curr Mol Med. 159-70. 5
155. Kenyon J, Gerson SL. The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res. 2007, 35:7557-65.
156. Nijnik A, Woodbine L, Marchetti C. DNA repair is limiting for haematopoietic stem cells during ageing. Nature. 2007, 447:686-90.
157. Chigancas V, Lima-Bessa KM, Stary A. Defective transcription/repair factor IIH recruitment to specific UV lesions in trichothiodystrophy syndrome. Cancer Res. 2008, 68:6074-83.
158. Redondo P, Prieto J, Munoz IG. Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. Nature. 2008, 456:107-11.
159. de Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B. 2001, 63:19-27.
160. Couve-Privat S, Bouadjar B, Avril MF. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res. 2002, 62:7186-9.
161. Ya-Grosjean L, Sarasin A. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients. Mutat Res. 2000, 450:193-9.
162. Nijhof JG, van Pelt C, Mulder AA. Epidermal stem and progenitor cells in murine epidermis accumulate UV damage despite NER proficiency. Carcinogenesis. 2007, 28:792-800.
163. Siegl-Cachedenier I, Flores I, Klatt P. Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres. J Cell Biol. 2007, 179:277-90.
164. Espada J, Varela I, Flores I. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J Cell Biol. 2008, 181:27-35.
165. Sommer M, Poliak N, Upadhyay S. DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle. 2006, 5:2005-11.
166. Bouillet P, Cory S, Zhang LC. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell. 2001, 1:645-53.
167. Sharpless E, Chin L. The INK4a/ARF locus and melanoma. Oncogene. 2003, 22:3092-8.
168. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004, 432:307-15.
169. Zhao Y, Chaiswing L, Bakthavatchalu V. Ras mutation promotes p53 activation and apoptosis of skin keratinocytes. Carcinogenesis. 2006, 27:1692-8.
170. Gonzalez-Suarez E, Samper E, Flores JM. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet. 2000, 26:114-7.
171. Cosme-Blanco W, Shen MF, Lazar AJ. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep. 2007, 8:497-503.
172. Munoz P, Blanco R, Flores JM. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nat Genet. 2005, 37:1063-71.
173. Lu J, Rho O, Wilker E. Activation of epidermal akt by diverse mouse skin tumor promoters. Mol Cancer Res. 2007, 5:1342-52.
174. Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS. 2007, 115:1161-76.
175. Yang SH, Andl T, Grachtchouk V. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta-catenin signaling. Nat Genet. 2008, 40:1130-5.
176. Mimeault M, Batra SK. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications. Ageing Res Rev. 2009, 8:94-112.
177. Kannan K, Sharpless NE, Xu J. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci USA. 2003, 100:1221-5.
178. Shimizu T, Izumi H, Oga A. Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology. 2001, 202:203-6.
179. Vidal VP, Ortonne N, Schedl A. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms. J Cutan Pathol. 2008, 35:373-9.
180. Tanese K, Fukuma M, Yamada T. G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. Am J Pathol. 2008, 173:835-43.
181. Aszterbaum M, Rothman A, Johnson RL. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 1998, 110:885-8.
182. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004, 432:324-31.
183. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006, 19:S127-47.
184. Reinisch CM, Uthman A, Erovic BM. Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions. J Cutan Pathol. 2007, 34:174-80.
185. Aszterbaum M, Epstein J, Oro A. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med. 1999, 5:1285-91.
186. Mancuso M, Pazzaglia S, Tanori M. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res. 2004, 64:934-41.
187. Dahmane N, Lee J, Robins P. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature. 1997, 389:876-81.
188. Fan H, Oro AE, Scott MP. Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med. 1997, 3:788-92.
189. Oro AE, Higgins K. Hair cycle regulation of Hedgehog signal reception. Dev Biol. 2003, 255:238-48.
190. Grachtchouk V, Grachtchouk M, Lowe L. The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J. 2003, 22:2741-51.
191. Nilsson M, Unden AB, Krause D. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA. 2000, 97:3438-43.
192. Athar M, Li C, Tang X. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res. 2004, 64:7545-52.
193. Nicolas M, Wolfer A, Raj K. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet. 2003, 33:416-21.
194. Gailani MR, Bale AE. Developmental genes and cancer: role of patched in basal cell carcinoma of the skin. J Natl Cancer Inst. 1997, 89:1103-9.
195. Chen KG, Szakacs G, Annereau JP. Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res. 2005, 18:102-12.
196. Hadnagy A, Gaboury L, Beaulieu R. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res. 2006, 312:3701-10.
197. Klein WM, Wu BP, Zhao S. Increased expression of stem cell markers in malignant melanoma. Mod Pathol. 2007, 20:102-7.
198. Bongiorno MR, Doukaki S, Malleo F. Identification of progenitor cancer stem cell in lentigo maligna melanoma. Dermatol Ther. 2008, 21:S1-5.
199. Strizzi L, Abbott DE, Salomon DS. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma. Cell Cycle. 2008, 7:1931-5.
200. Pinnix CC, Herlyn M. The many faces of Notch signaling in skin-derived cells. Pigment Cell Res. 2007, 20:458-65.
201. Gray-Schopfer VC, Cheong SC, Chong H. Cellular senescence in naevi and immortalisation in melanoma: a role for p16. Br J Cancer. 2006, 95:496-505.
202. Bardeesy N, Kim M, Xu J. Role of epidermal growth factor receptor signaling in RAS-driven melanoma. Mol Cell Biol. 2005, 25:4176-88.
203. Weeraratna AT, Jiang Y, Hostetter G. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002, 1:279-88.
204. Dhomen N, Reis-Filho JS, da Rocha DS. Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell. 2009, 15:294-303.
205. Curtin JA, Fridlyand J, Kageshita T. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005, 353:2135-47.
206. Curtin JA, Busam K, Pinkel D. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006, 24:4340-6.
207. Grafstrom E, Egyhazi S, Ringborg U. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival. Clin Cancer Res. 2005, 11:2991-7.
208. Poynter JN, Elder JT, Fullen DR. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res. 16:267-73.
209. Jonsson G, Dahl C, Staaf J. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene. 2007, 26:4738-48.
210. Smalley KS, Contractor R, Nguyen TK. Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression. Cancer Res. 2008, 68:5743-52.
211. Quintana E, Shackleton M, Sabel MS. Efficient tumour formation by single human melanoma cells. Nature. 2008, 456:593-8.
212. Metcalf S, Crowson AN, Naylor M. Imiquimod as an antiaging agent. J Am Acad Dermatol. 2007, 56:422-5.
213. Bellizzi D, Rose G, Cavalcante P. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics. 2005, 85:258-63.
214. Fisher GJ, Wang ZQ, Datta SC. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997, 337:1419-28.
215. Giannakou ME, Partridge L. The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol. 2004, 14:408-12.
216. Mantel C, Broxmeyer HE. Sirtuin 1, stem cells, aging, and stem cell aging. Curr Opin Hematol. 15:326-31.
217. Trapp J, Jung M. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Curr Drug Targets. 2006, 7:1553-60.
218. Seve M, Chimienti F, Devergnas S. Resveratrol enhances UVA-induced DNA damage in HaCaT human keratinocytes. Med Chem. 2005, 1:629-33.
219. Davids LM, du Toit E, Kidson SH. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes. Clin Exp Dermatol. 2009, 34:246-8.
220. Yu BD, Mukhopadhyay A, Wong C. Skin and hair: models for exploring organ regeneration. Hum Mol Genet. 2008, 17:R54-9.
221. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007, 445:851-7.
222. Mimeault M, Hauke R, Mehta PP. Recent advances on cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Mol Cell Med. 2007, 11:981-1011.
223. Mimeault M, Batra SK. Recent advances on the development of novel anti-cancer drugs targeting cancer stem/progenitor cells. Drug Develop Res. 2008, 69:415-30.
224. Tang JY, So PL, Epstein EH. Novel Hedgehog pathway targets against basal cell carcinoma. Toxicol Appl Pharmacol. 2006, 224:257-64.
225. Singh B, Schneider M, Knyazev P. UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines. Int J Cancer. 2009, 124:531-9.
226. Stecca B, Mas C, Clement V. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA. 2007, 104:5895-00.
227. Kirkwood JM, Tarhini AA, Panelli MC. Next generation of immunotherapy for melanoma. J Clin Oncol. 2008, 26:3445-55.
228. Remsberg JR, Lou H, Tarasov SG. Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth. J Med Chem. 2007, 50:4534-8.
229. Chen GS, Yu HS, Lan CC. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br J Dermatol. 2006, 154:910-8.
230. Kim Y, Lee YS, Choe J. CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. J Biol Chem. 2008, 283:22513-28.
231. Qiu L, Wang Q, Di W. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Int J Oncol. 2005, 27:823-30.
232. Deng Y, Chang S. Role of telomeres and telomerase in genomic instability, senescence and cancer. Lab Invest. 2007, 87:1071-6.
233. Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer. 2008, 8:167-79.
234. Shay JW, Keith WN. Targeting telomerase for cancer therapeutics. Br J Cancer. 2008, 98:677-83.
235. Phatak P, Burger AM. Telomerase and its potential for therapeutic intervention. Br J Pharmacol. 2007, 152:1003-11.
236. Cortez-Gonzalez X, Zanetti M. Telomerase immunity from bench to bedside: round one. J Transl Med. 2007, 5:12.
237. Brown AJ. Cholesterol, statins and cancer. Clin Exp Pharmacol Physiol. 2007, 34:135-41.
238. Cooper MK, Wassif CA, Krakowiak PA. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet. 2003, 33:508-13.
239. Bijlsma MF, Spek CA, Zivkovic D. Repression of smoothened by patched-dependent (pro-) vitamin D3 secretion. PLoS Biol. 2006, 4. e232
240. Williams JA, Guicherit OM, Zaharian BI. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA. 2003, 100:4616-21.
241. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008, 8:743-54.
242. Garber K. Hedgehog drugs begin to show results. J Natl Cancer Inst. 2008, 100:692-7.
243. Hodi FS, Friedlander P, Corless CL. Major response to imatinib mesylate in KIT-mutated melanoma. J Clin Oncol. 2008, 26:2046-51.
244. Knight LA, Di Nicolantonio F, Whitehouse P. The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours. BMC Cancer. 2004, 4:83.
245. Postovit LM, Margaryan NV, Seftor EA. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA. 2008, 105:4329-34.
246. Nickoloff BJ, Hendrix MJ, Pollock PM. Notch and NOXA-related pathways in melanoma cells. J Investig Dermatol Symp Proc. 2005, 10:95-104.
247. Guo Y, Ma J, Wang J. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 1994, 54:1561-5.
248. Ahrens T, Sleeman JP, Schempp CM. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene. 2001, 20:3399-408.
249. Bartolazzi A, Peach R, Aruffo A. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med. 1994, 180:53-66.
250. Yokoyama S, Feige E, Poling LL. Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage. Pigment Cell Melanoma Res. 2008, 21:457-63.
251. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004, 351:998-1012.
252. den Brok MH, Nierkens S, Figdor CG. Dendritic cells: tools and targets for antitumor vaccination. Expert Rev Vaccines. 2005, 4:699-710.
253. Sigalotti L, Covre A, Zabierowski S. Cancer testis antigens in human melanoma stem cells: Expression, distribution, and methylation status. J Cell Physiol. 2008, 215:287-91.
254. Aboody KS, Bush RA, Garcia E. Development of a tumor-selective approach to treat metastatic cancer. PLoS ONE. 2006, 1. e23
255. Gedye C, Quirk J, Browning J. Cancer/testis antigens can be immunological targets in clonogenic CD133(+) melanoma cells. Cancer Immunol Immunother. 2009, 58:1635-46.